The London Clinic Performs a ‘World’s First’ with BioPoly Partial Knee Resurfacing
April 25, 2012
On the 9th January, The London Clinic consultant Mr. Dinesh Nathwani successfully performed the world's first BioPoly partial knee resurfacing procedure.
BioPoly Receives CE Mark Approval to Market Knee Product in Europe
June 1, 2011
FORT WAYNE, IN —BioPoly LLC, has received official notice of its CE mark for its partial resurfacing knee product line, allowing the company to market these products in Europe, according to company officials. As a result, the company is planning to launch the BioPoly™ RS Partial Resurfacing Knee Implant system in Europe later this year.
Fort Wayne Orthopaedic Company, BioPoly LLC, Fully Subscribes 2nd Round of Equity Financing: $2.5M
May 3, 2011
FORT WAYNE, IN —BioPoly LLC, a Schwartz Biomedical subsidiary, has fully subscribed its 2nd round of equity financing ($2.5M) according to company officials. This capital will be used to launch its first orthopaedic product into the European market and to continue the development of multiple orthopaedic applications that use the BioPoly™ technology.
Orthopaedic Company, BioPoly LLC, Announces Issuance of Patent
February 18, 2010
FORT WAYNE, IN — BioPoly LLC, a local orthopaedic device manufacturer and Schwartz Biomedical subsidiary, announces that one of its key patents has issued. The issuance of this patent protects the BioPoly™ material claims and provides the company with a unique competitive advantage. This patent is one of an entire family of patents that have been filed to protect this technology. BioPoly LLC obtained an exclusive license for this technology from Colorado State University.
BioPoly™ Raises $2M for Commercialization of Orthopaedic Products
January 12, 2010
FORT WAYNE, IN — BioPoly LLC, a Schwartz Biomedical subsidiary, has raised more than $2M in its first round of equity financing. This capital will be used to complete product development and initiate the launch of its first orthopaedic products into the market. Although this capital represents the first round of equity financing, initial support for this venture was provided by nearly $4M from two Indiana 21 Fund grants and other internal funding sources.
Fort Wayne Orthopaedic Company Receives Technology Funding
May 1, 2007
FORT WAYNE, IN — Schwartz Biomedical subsidiary, BioPoly LLC, has been awarded $2MM from Indiana’s 21st Century Fund to develop a new orthopaedic implant, called BioPoly™ RS (ReSurfacing), which will be used to replace only the damaged portion of a joint (i.e. knee, hip, shoulder, phalanges, etc…) as opposed to the entire joint. Patients receiving this new implant will not have to put up with chronic pain that many arthritis sufferers endure while they wait for their joint to deteriorate to the point where they are total joint replacement candidates.